KPTI - Karyopharm Therapeutics Inc. (KPTI) CEO Dr. Michael Kauffman on Q1 2019 Results - Earnings Call Transcript
Karyopharm Therapeutics Inc. (KPTI)
Q1 2019 Results Conference Call
May 09, 2019 08:30 AM ET
Company Participants
Ian Karp - VP, IR and Public Relations
Dr. Michael Kauffman - CEO
Mike Mason - CFO
Anand Varadan - Chief Commercial Officer
Conference Call Participants
Brian Abrahams - RBC Capital Markets
David Ruch - SVB Leerink
Presentation
Operator
Good morning. My name is Gigi and I will be your conference operator today. At this time, I would like to welcome everyone to the Karyopharm Therapeutics First Quarter 2019 Financial Results Conference Call. There will be a question-and-answer